Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 10.30
+0.27 (2.69%)
Feb 4, 2026, 11:54 AM CST
SHE:300016 Revenue
Beijing Beilu Pharmaceutical had revenue of 288.48M CNY in the quarter ending September 30, 2025, with 12.78% growth. This brings the company's revenue in the last twelve months to 1.13B, up 16.06% year-over-year. In the year 2024, Beijing Beilu Pharmaceutical had annual revenue of 983.55M with 10.42% growth.
Revenue (ttm)
1.13B
Revenue Growth
+16.06%
P/S Ratio
5.01
Revenue / Employee
960.38K
Employees
1,173
Market Cap
5.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 983.55M | 92.84M | 10.42% |
| Dec 31, 2023 | 890.72M | 124.84M | 16.30% |
| Jan 1, 2023 | 765.88M | -94.02M | -10.93% |
| Jan 1, 2022 | 859.91M | 32.57M | 3.94% |
| Dec 31, 2020 | 827.34M | 8.22M | 1.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Guizhou Bailing Group Pharmaceutical | 3.15B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.92B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Jiangsu Jibeier Pharmaceutical | 957.76M |
| Nanjing Hicin Pharmaceutical | 615.39M |